PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs
February 11, 2008 | David P. Hamilton
See our story about this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Bay Area regulators consider tax on greenhouse gas emissions
Previous Story: Sequans raises $28M for WiMAX chips
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
East Coast Editor
Dean TakahashiLead Writer, GamesBeat
National Editor, MobileBeat Lead
Executive Editor
Editor-in-Chief, GamesBeat
Senior Editor
Writer
Writer
Founder & Editor-in-Chief
Writer
Editorial Assistant
Writer
Reviews Editor, GamesBeat
Tom CheredarWriter
Contributor
Julia PlevinContributor
Contributor









